FDA approves first generic of Xeloda for colon cancer
The US Food and Drug Administration has given approval to Teva Pharmaceuticals for the first generic version of Roche's colon cancer drug Xeloda.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Food and Drug Administration (FDA) | Pharmaceuticals | Xeloda